Lumacaftor/ivacaftor, a novel agent for the treatment of cystic fibrosis patients who are homozygous for the F580del CFTR mutation
Bulloch, Marilyn N., Hanna, Cameron, Giovane, RichardМова:
english
Журнал:
Expert Review of Clinical Pharmacology
DOI:
10.1080/17512433.2017.1378094
Date:
September, 2017
Файл:
PDF, 1.66 MB
english, 2017